| Gail M Herzig, MD | |
|
45b Discovery Way, Acton, MA 01720-4482 | |
| (978) 429-2010 | |
| (978) 264-1935 |
| Full Name | Gail M Herzig |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 36 Years |
| Location | 45b Discovery Way, Acton, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689608440 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 80319 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emerson Hospital - | W concord, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Middlesex Gastroenterolgy Pc | 6800819566 | 11 |
News Archive
What unique health needs will Syrian refugees face, and how can Canadian physicians best provide health care to them and their families? A practice article posted online today in CMAJ (Canadian Medical Association Journal) provides recommendations on screening and advice for primary care physicians to deal with this specific population's health care needs.
In 2001, a Charleston, W.Va., a hospital and three community health centers set up a Community Access Program to help give low-income residents a primary health care system in the hopes of lowering emergency room care. The program has enrolled 5,000 people and "cut their hospital use in half," the Charleston Gazette reports.
The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.
The world's rising obesity epidemic is associated with a broad spectrum of ailments including atherosclerosis and non-alcoholic fatty liver disease.
There is no danger if your child received the H1N1 vaccine that was recalled by Sanofi Pasteur. That is the information being provided to anyone calling the NJ Poison Control Center's hotline, according to Bruce Ruck, Pharm.D., Director of Drug Information and Professional Education. The public should be reassured that this recall took place because specific lots were found to be slightly weaker than they should have been.
› Verified 7 days ago
| Entity Name | Middlesex Gastroenterolgy Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992845911 PECOS PAC ID: 6800819566 Enrollment ID: O20060109000379 |
News Archive
What unique health needs will Syrian refugees face, and how can Canadian physicians best provide health care to them and their families? A practice article posted online today in CMAJ (Canadian Medical Association Journal) provides recommendations on screening and advice for primary care physicians to deal with this specific population's health care needs.
In 2001, a Charleston, W.Va., a hospital and three community health centers set up a Community Access Program to help give low-income residents a primary health care system in the hopes of lowering emergency room care. The program has enrolled 5,000 people and "cut their hospital use in half," the Charleston Gazette reports.
The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.
The world's rising obesity epidemic is associated with a broad spectrum of ailments including atherosclerosis and non-alcoholic fatty liver disease.
There is no danger if your child received the H1N1 vaccine that was recalled by Sanofi Pasteur. That is the information being provided to anyone calling the NJ Poison Control Center's hotline, according to Bruce Ruck, Pharm.D., Director of Drug Information and Professional Education. The public should be reassured that this recall took place because specific lots were found to be slightly weaker than they should have been.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gail M Herzig, MD 45b Discovery Way, Acton, MA 01720-4482 Ph: (978) 429-2010 | Gail M Herzig, MD 45b Discovery Way, Acton, MA 01720-4482 Ph: (978) 429-2010 |
News Archive
What unique health needs will Syrian refugees face, and how can Canadian physicians best provide health care to them and their families? A practice article posted online today in CMAJ (Canadian Medical Association Journal) provides recommendations on screening and advice for primary care physicians to deal with this specific population's health care needs.
In 2001, a Charleston, W.Va., a hospital and three community health centers set up a Community Access Program to help give low-income residents a primary health care system in the hopes of lowering emergency room care. The program has enrolled 5,000 people and "cut their hospital use in half," the Charleston Gazette reports.
The U.S. Food and Drug Administration today approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and adolescents age 12 and older with rare tumors of the adrenal gland (pheochromocytoma or paraganglioma) that cannot be surgically removed (unresectable), have spread beyond the original tumor site and require systemic anticancer therapy.
The world's rising obesity epidemic is associated with a broad spectrum of ailments including atherosclerosis and non-alcoholic fatty liver disease.
There is no danger if your child received the H1N1 vaccine that was recalled by Sanofi Pasteur. That is the information being provided to anyone calling the NJ Poison Control Center's hotline, according to Bruce Ruck, Pharm.D., Director of Drug Information and Professional Education. The public should be reassured that this recall took place because specific lots were found to be slightly weaker than they should have been.
› Verified 7 days ago
Amy Churchill, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 321 Main St, Acton, MA 01720 Phone: 978-263-1131 | |
Arpan H. Patel, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 45 B Discovery Way, Acton, MA 01720 Phone: 978-429-2010 Fax: 978-264-1986 | |
Dr. Peter James Demartino, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 321 Main St, Acton, MA 01720 Phone: 978-263-1425 | |
Teli Leung-galecki, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 321 Main St, Acton, MA 01720 Phone: 978-635-8700 Fax: 978-635-8920 | |
Dr. Ingrid Gorman, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 321 Main St, Acton, MA 01720 Phone: 978-263-1131 | |
Dr. Lauren Michele Bleich, MD/MPH Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 45b Discovery Way, Acton, MA 01720 Phone: 978-429-2010 Fax: 978-264-1935 | |
Dr. Claudia Talland, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 321 Main St, Acton, MA 01720 Phone: 978-263-1131 |